1. Home
  2. ALBT vs BDRX Comparison

ALBT vs BDRX Comparison

Compare ALBT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • BDRX
  • Stock Information
  • Founded
  • ALBT 2014
  • BDRX 2000
  • Country
  • ALBT United States
  • BDRX United Kingdom
  • Employees
  • ALBT N/A
  • BDRX N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALBT Health Care
  • BDRX Health Care
  • Exchange
  • ALBT Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • ALBT 9.5M
  • BDRX 9.6M
  • IPO Year
  • ALBT N/A
  • BDRX N/A
  • Fundamental
  • Price
  • ALBT $0.42
  • BDRX $0.80
  • Analyst Decision
  • ALBT
  • BDRX Strong Buy
  • Analyst Count
  • ALBT 0
  • BDRX 1
  • Target Price
  • ALBT N/A
  • BDRX $8.00
  • AVG Volume (30 Days)
  • ALBT 84.1K
  • BDRX 4.2M
  • Earning Date
  • ALBT 08-12-2024
  • BDRX 04-19-2024
  • Dividend Yield
  • ALBT N/A
  • BDRX N/A
  • EPS Growth
  • ALBT N/A
  • BDRX N/A
  • EPS
  • ALBT N/A
  • BDRX N/A
  • Revenue
  • ALBT $959,516.00
  • BDRX $482,278.00
  • Revenue This Year
  • ALBT N/A
  • BDRX N/A
  • Revenue Next Year
  • ALBT N/A
  • BDRX N/A
  • P/E Ratio
  • ALBT N/A
  • BDRX N/A
  • Revenue Growth
  • ALBT 6.08
  • BDRX N/A
  • 52 Week Low
  • ALBT $0.24
  • BDRX $0.67
  • 52 Week High
  • ALBT $1.70
  • BDRX $9.64
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 44.94
  • BDRX 42.17
  • Support Level
  • ALBT $0.45
  • BDRX $0.91
  • Resistance Level
  • ALBT $0.49
  • BDRX $1.20
  • Average True Range (ATR)
  • ALBT 0.05
  • BDRX 0.14
  • MACD
  • ALBT -0.01
  • BDRX 0.00
  • Stochastic Oscillator
  • ALBT 8.04
  • BDRX 9.48

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: